ATXN7 Antikörper (Middle Region)
Kurzübersicht für ATXN7 Antikörper (Middle Region) (ABIN927440)
Target
Alle ATXN7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- Middle Region
- 
                                            Kreuzreaktivität
- Ratte (Rattus), Maus, Hund, Huhn
- 
                                            Aufreinigung
- Purified
- 
                                            Immunogen
- ATXN7 antibody was raised in rabbit using the middle region of ATXN7 as the immunogen
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- 
                        WB: 0.2-1 µg/mL
 Optimal conditions should be determined by the investigator.
- 
                                            Kommentare
- 
                        ATXN7 Blocking Peptide, (ABIN5612243), is also available for use as a blocking control in assays to test for specificity of this ATXN7 antibody 
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Lyophilized
- 
                                            Konzentration
- Lot specific
- 
                                            Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- 
                                            Handhabung
- Avoid repeated freeze/thaw cycles.
- 
                                            Lagerung
- 4 °C/-20 °C
- 
                                            Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
 
- 
                                            
- 
    - ATXN7 (Ataxin 7 (ATXN7))
- 
                                            Andere Bezeichnung
- ATXN7
- 
                                            Hintergrund
- ATXN7 is involved in neurodegeneration. ATXN7 acts as component of the STAGA transcription coactivator-HAT complex. ATXN7 mediates the interaction of STAGA complex with the CRX and is involved in CRX-dependent gene activation.The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Synonyms: Polyclonal ATXN7 antibody, Anti-ATXN7 antibody, ataxin 7 antibody, ADCAII antibody, OPCA3 antibody, SCA7 antibody.
 Target
- 
                    
 
                                     
                                     
                                    